Evidence map›Paper›PMID 8387478›Full record

ArticleJapanese journal of cancer research : Gann1993

Establishment and characterization of a simian virus 40-immortalized osteoblastic cell line from normal human bone.

H Chiba, N Sawada, T Ono, S Ishii, M Mori

Open access · bronzeAbstract read
In one paragraph

Article in Japanese journal of cancer research : Gann, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Follistatin Effects in Migration, Vascularization, and OsteogenesisFrontiers in bioengineering and biotechnology · 2019
    Article
  3. Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

H ChibaDepartment of Pathology, Sapporo Medical College.
N Sawada
T Ono
S Ishii
M Mori
Sapporo Medical University · JPHokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We established a human osteoblastic cell line immortalized by simian virus 40 (SV40) in vitro, and designated it SV-HFO. Immunocytochemically, the cells were positive for SV40 large T-antigen, vimentin and osteocalcin, but negative for keratin and epithelial membrane antigen. The cells had characteristic morphologic and ultrastructural features of osteoblasts, produced alkaline phosphatase, and synthesized osteocalcin, the levels of which were elevated by treatment of the cells with 1a,25-dihydroxyvitamin D3. The cells proliferated and showed such osteoblastic properties even under serum-free conditions. The cells grew in soft agar, but did not form tumors when transplanted into athymic nude mice. Karyotypic analysis by the Q-banding technique showed that these cells were of human origin. The SV-HFO cell line is expected to serve as a suitable model for studying metabolism and carcinogenesis in human bone.

Indexed as

Cell Line, TransformedCell Transformation, ViralSimian virus 40Alkaline PhosphataseAnimalsAntigens, Polyomavirus TransformingCalcitriolCell DivisionCulture MediaHumansImmunohistochemistryKaryotypingMiceMice, NudeMicroscopy, ElectronMicroscopy, Phase-ContrastAlkaline PhosphataseAntigens, Polyomavirus TransformingCalcitriolCulture MediaOsteocalcinVimentin

Identifiers

PMID8387478
PMCPMC5919145
OpenAlexW1990234191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.